Relay Therapeutics, Inc. (RLAY)
Latest RLAY Insider Trades
About Relay Therapeutics, Inc. (RLAY)
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.
- CAMBRIDGE, MA
- 192
- 2020
- XNAS
90-Day SEC Filing Activity
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 16 | 6,480,063 | $125.05M |
| Grant or award | 9 | 236,741 | |
| Option exercise | 8 | 525,804 |
RLAY Insider Transactions (Form 4)
4059 Form 4 filings on record, the earliest from Oct 1, 2024, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sanjiv Patel - Officer | Grant or award | Common Stock | 994 |
Recent RLAY Form 8-K Filings
5Recent RLAY Form 144 Notices of Proposed Sale
3A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| PETER RAHMER | Officer | 50,000 | $1.03M | View on EDGAR | |
| SVF Pauling (Cayman) Ltd | Stockholder |
RLAY Insider Trading - FAQ
What is the latest insider trade for RLAY?
Relay Therapeutics, Inc. (RLAY) had 20 insider filings in the last 90 days, with the most recent on 2026-08-28. The full record for RLAY runs to 59 Form 4 filings, the earliest from 2024-10-01. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying RLAY stock?
No insider purchases of RLAY were filed in the last 90 days.
How many insiders are selling RLAY stock?
16 insider sales of RLAY were filed in the last 90 days, totaling $125.05M.
Where can I see RLAY SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks RLAY Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow RLAY insider buys?
Create a free InsiderAlpha account and press Watch on this page to add RLAY to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity
Recent Insider Filings
10Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
- - Peter Rahmer view on EDGAR
- - SVF Pauling (Cayman) Ltd view on EDGAR
- - Sanjiv Patel view on EDGAR
- - Thomas Catinazzo view on EDGAR
- - Thomas Catinazzo view on EDGAR
- - Peter Rahmer view on EDGAR
- - Donald A. Bergstrom view on EDGAR
- - Donald A. Bergstrom view on EDGAR
- - Sanjiv Patel view on EDGAR
Related Companies - Recent Insider Activity
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity in Health Care
- Where RLAY's peers are being bought and sold.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track RLAY insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
